GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹903 Cr | ₹1,290 Cr | ₹582 Cr | ₹484 Cr | ₹811 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹903 Cr |
| Mar2025 | ₹1,290 Cr |
| Mar2024 | ₹582 Cr |
| Mar2023 | ₹484 Cr |
| Mar2022 | ₹811 Cr |
How is Cash Flow from Operating Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹903 Cr | -29.97 | |
| Mar2025 | ₹1,290 Cr | 121.63 | |
| Mar2024 | ₹582 Cr | 20.20 | |
| Mar2023 | ₹484 Cr | -40.27 | |
| Mar2022 | ₹811 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,902.2 Cr | 0.7% | -7.4% | -2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 0.7% |
-7.4% |
-2.6% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses